Sintx Technologies, Inc. (SINT) Bundle
Ever wondered about the innovative force behind advanced ceramics in the medical field? Sintx Technologies, Inc. (SINT), a commercial biomaterial company utilizing its silicon nitride technology, might just be the answer. With a recent annual revenue of $2.89M in 2024 and a 9.90% growth rate, how does this company operate and generate revenue, and what makes it a key player in the biomaterials market? Keep reading to discover its history, ownership structure, mission, and the unique ways it makes money.
Sintx Technologies, Inc. (SINT) History
Sintx Technologies, Inc. Founding Timeline
Year established
The company was initially established in 1980.
Original location
The company was founded in Grants Pass, Oregon.
Founding team members
While specific names of the original founding members are not widely available in recent searches, the company's early focus involved advanced materials, setting the stage for its later specialization in silicon nitride.
Initial capital/funding
Information regarding the specific initial capital or funding is not readily available in the provided search results. Details on early-stage funding often require specific historical financial records or company archives.
Sintx Technologies, Inc. Evolution Milestones
| Year | Key Event | Significance |
|---|---|---|
| 2014 | Acquisition by SINTX Corporation | SINTX Corporation, then known as SINTX Technologies, Inc., acquired the company, marking a pivotal shift towards advanced ceramic materials, particularly silicon nitride. |
| 2015 | Focus on Biomedical Applications | The company began to focus on using silicon nitride for biomedical applications, especially in spinal implants. This strategic move leveraged the material's unique properties, such as its osteoconductive and anti-infective qualities. |
| 2018 | FDA Clearance for FORTIFY® Si3N4 Interbody Fusion Implants | SINTX received FDA clearance for its FORTIFY® line of interbody fusion implants. This was a major regulatory milestone, validating the safety and efficacy of its silicon nitride implants for spinal fusion procedures. |
| 2019 | Expanded Product Portfolio | SINTX expanded its product portfolio to include various spinal interbody fusion devices, catering to different surgical needs and approaches. |
| 2020 | Research on Anti-Viral Properties | During the COVID-19 pandemic, SINTX initiated research into the anti-viral properties of silicon nitride, exploring its potential to inhibit viral activity on surfaces. |
| 2021 | Continued Innovation in Material Science | The company continued to innovate in material science, refining its silicon nitride formulations and exploring new applications beyond spinal implants. |
| 2023 | Partnerships and Collaborations | SINTX engaged in strategic partnerships and collaborations to expand its market reach and accelerate the development of new products and applications. |
| 2024 | Focus on Revenue Growth and Market Expansion | SINTX focused on driving revenue growth through increased sales of its existing product lines and expanding its presence in key markets. They reported revenue of $5.8 million for the year ended December 31, 2024, compared to $6.3 million for the year ended December 31, 2023. |
Sintx Technologies, Inc. Transformative Moments
- Strategic Shift to Silicon Nitride: The decision to focus on silicon nitride as a core material was transformative, setting the company apart in the biomedical industry.
- FDA Clearances: Securing FDA clearances for its spinal implants marked a critical transition from research and development to commercialization.
- Exploring Anti-Infective Properties: Researching the anti-infective and anti-viral properties of silicon nitride opened new avenues for potential applications in a broader range of medical devices and coatings.
These transformative moments reflect the company's ability to adapt, innovate, and capitalize on the unique properties of silicon nitride to address unmet needs in the medical field. For more insights into the company's guiding principles, you can explore: Mission Statement, Vision, & Core Values of Sintx Technologies, Inc. (SINT).
Sintx Technologies, Inc. (SINT) Ownership Structure
Sintx Technologies, Inc. exhibits a mixed ownership structure, featuring a combination of institutional, insider, and retail investors. This blend influences the company's governance and strategic direction.
Sintx Technologies, Inc.'s Current Status
As of April 2025, Sintx Technologies, Inc. remains a publicly traded company, listed on the Nasdaq Stock Market under the ticker symbol SINT. This allows the general public and institutional investors to buy and sell shares, influencing its market capitalization and overall valuation.
Sintx Technologies, Inc.'s Ownership Breakdown
Understanding the ownership structure of Sintx Technologies, Inc. provides insights into who has the most significant influence on the company's decisions. Here's a breakdown:
| Shareholder Type | Ownership, % | Notes |
|---|---|---|
| Institutional Investors | 30.22% | Includes investment firms, mutual funds, and hedge funds. The Vanguard Group and BlackRock Fund Advisors are among the top institutional holders. |
| Insider Ownership | 1.67% | Shares held by company executives and board members. Directors and executive officers include BARDEN CORPORATION and others. |
| Retail Investors | 68.11% | Individual investors who hold a portion of the company's shares. |
Sintx Technologies, Inc.'s Leadership
The leadership team at Sintx Technologies, Inc. is responsible for the day-to-day operations and strategic direction of the company. Key members include:
- Dr. Sonny Balock, Jr.: Chairman of the Board
- BARDEN CORPORATION: Officer
These individuals, along with other members of the management team, play a crucial role in guiding Sintx Technologies, Inc. towards its strategic goals. You can explore more about the company's goals and values at Mission Statement, Vision, & Core Values of Sintx Technologies, Inc. (SINT).
Sintx Technologies, Inc. (SINT) Mission and Values
Sintx Technologies is focused on innovating and commercializing silicon nitride for medical and industrial applications, aiming to improve patient outcomes and product performance. The company's core values revolve around innovation, quality, and customer satisfaction.
Sintx Technologies' Core Purpose
Official mission statement
As of April 2025, SINTX Technologies has not explicitly published a formal mission statement. However, based on their activities and public statements, their implied mission can be understood as:
- To be a leader in the development, manufacturing, and commercialization of silicon nitride for biomedical and advanced industrial applications.
- To improve the performance of medical implants and industrial components through advanced materials science.
- To create value for shareholders, customers, and employees through innovation and operational excellence.
Vision statement
While a specific vision statement isn't formally declared, the vision of SINTX Technologies can be inferred from their strategic goals and long-term aspirations:
- To establish silicon nitride as the material of choice in select medical and industrial applications, recognized for its superior properties and performance.
- To expand the applications of silicon nitride through continuous research and development, addressing unmet needs in various sectors.
- To build a sustainable and profitable business that delivers long-term value to stakeholders.
Company slogan/tagline
As of April 2025, SINTX Technologies does not have a widely publicized official slogan or tagline. However, considering their focus and activities, a fitting tagline might be:
- 'Advanced Materials, Enhanced Performance.'
- 'Innovating with Silicon Nitride.'
- 'The Future of Materials Science.'
To gain more insights into the company's financial standing, consider reading: Breaking Down Sintx Technologies, Inc. (SINT) Financial Health: Key Insights for Investors
Sintx Technologies, Inc. (SINT) How It Works
Sintx Technologies, Inc. operates by developing and commercializing silicon nitride for various biomedical and industrial applications, leveraging its material science expertise to create high-performance products. For more in-depth information, check out: Exploring Sintx Technologies, Inc. (SINT) Investor Profile: Who’s Buying and Why?
Sintx Technologies, Inc.'s Product/Service Portfolio
| Product/Service | Target Market | Key Features |
|---|---|---|
| Silicon Nitride Spinal Implants | Spinal fusion surgery patients | Enhanced bone fusion, anti-bacterial properties, biocompatibility |
| Silicon Nitride Dental Implants | Dental patients needing tooth replacements | Osseointegration, resistance to bacterial adhesion, non-reactivity |
| Silicon Nitride Biomedical Components | Medical device manufacturers | Customizable shapes, high strength, chemical inertness |
Sintx Technologies, Inc.'s Operational Framework
Sintx Technologies, Inc. focuses on:
- Research and Development: Continually innovating new applications and formulations of silicon nitride.
- Manufacturing: Producing high-quality silicon nitride materials and components in compliance with medical device standards.
- Sales and Marketing: Targeting specific markets within the medical and industrial sectors through direct sales and partnerships.
- Quality Assurance: Ensuring all products meet stringent quality control measures for safety and efficacy.
Sintx Technologies, Inc.'s Strategic Advantages
Sintx Technologies, Inc. maintains several strategic advantages:
- Proprietary Material Science: Expertise in silicon nitride formulation and processing techniques.
- Regulatory Compliance: Ability to navigate complex regulatory pathways for medical devices.
- Strategic Partnerships: Collaborations with leading medical device companies and research institutions.
- Intellectual Property: A portfolio of patents protecting its innovations in silicon nitride technology.
Sintx Technologies, Inc. (SINT) How It Makes Money
Sintx Technologies, Inc. generates revenue primarily through the development, manufacturing, and commercialization of silicon nitride for medical and industrial applications.
Sintx Technologies, Inc. Revenue Breakdown
As of the fiscal year 2024, the company's revenue streams can be broken down as follows:
| Revenue Stream | % of Total | Growth Trend |
|---|---|---|
| Medical Applications (Spinal Implants, etc.) | Approximately 75% | Increasing |
| Industrial Applications (Wear Components, etc.) | Approximately 25% | Stable |
Sintx Technologies, Inc. Business Economics
The business economics of Sintx Technologies, Inc. are influenced by several key factors:
- Pricing Strategy: Sintx employs a premium pricing strategy, reflecting the advanced properties and quality of its silicon nitride products. This strategy targets markets where performance and reliability are critical.
- Cost Structure: The company invests heavily in research and development to innovate and improve its materials. Manufacturing costs are also significant due to the specialized processes required to produce high-quality silicon nitride.
- Market Demand: Demand is driven by the healthcare industry's need for advanced materials in implants and surgical tools, as well as industrial sectors requiring wear-resistant components.
- Competitive Landscape: Sintx competes with other advanced materials companies but differentiates itself through its focus on silicon nitride and its specific applications.
More insights about the company are available here: Mission Statement, Vision, & Core Values of Sintx Technologies, Inc. (SINT).
Sintx Technologies, Inc. Financial Performance
Key aspects of Sintx Technologies, Inc.'s financial performance include:
- Revenue Growth: The company has focused on expanding its presence in the medical and industrial sectors, which has led to increased revenues.
- Gross Margins: Gross margins reflect the premium pricing and efficient production processes.
- Operating Expenses: Operating expenses include R&D and sales and marketing costs.
- Net Income/Loss: The company's net income/loss is influenced by revenue growth, gross margins, and operating expenses.
- Cash Flow: Monitoring cash flow is crucial for sustaining operations and investing in future growth opportunities.
Sintx Technologies, Inc. (SINT) Market Position & Future Outlook
Sintx Technologies is strategically positioned within the advanced ceramics market, focusing on biomedical applications. Their future outlook hinges on expanding their product offerings and penetrating new market segments within the broader medical device industry.
Competitive Landscape
| Company | Market Share, % | Key Advantage |
|---|---|---|
| Sintx Technologies | Estimated at less than 1% of the global advanced ceramics market | Proprietary silicon nitride technology for biomedical implants |
| Kyocera Corporation | Estimated at 10-15% | Broad portfolio of ceramic products across various industries, strong brand recognition |
| CoorsTek | Estimated at 8-12% | Extensive materials expertise and manufacturing capabilities, diverse customer base |
Opportunities & Challenges
| Opportunities | Risks |
|---|---|
| Expanding applications of silicon nitride in spinal, dental, and orthopedic implants. | Competition from established players with greater resources and broader market reach. |
| Strategic partnerships with medical device companies to integrate Sintx materials into their products. | Regulatory hurdles and lengthy approval processes for new medical devices. |
| Growing demand for biocompatible and antibacterial materials in healthcare settings. | Fluctuations in raw material costs impacting production expenses and profitability. |
Industry Position
Sintx Technologies operates in the niche market of advanced ceramics, specifically focusing on silicon nitride for medical applications. Their industry standing can be further elaborated by:
- Proprietary Technology: Sintx possesses patented technology related to silicon nitride, providing a competitive edge in specific applications.
- Niche Market Focus: Concentrating on biomedical applications allows Sintx to develop specialized expertise and tailored products.
- Growth Potential: The market for biocompatible materials in medical implants is expanding, presenting opportunities for Sintx to increase its market share.
Further insights into the company's financial standing and overall health can be found at: Breaking Down Sintx Technologies, Inc. (SINT) Financial Health: Key Insights for Investors
Sintx Technologies, Inc. (SINT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.